LISATA THERAPEUTICS, INC. — Director's Dealing 2013

Nov 25, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2013-11-12

Reporting Person: MYERS STEVEN S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-12	Common stock, par value $0.001 per share	P	8012	$6.25	Acquired	8012	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, par value $0.001 per share	104931	Direct
Common stock, par value $0.001 per share	19531	Indirect
Common stock, par value $0.001 per share	19531	Indirect